Craig Stubbs’ Post

View profile for Craig Stubbs, graphic

Director: Innovation News Network | Health Europa

Innovation News Network health partner Defence Therapeutics Defence Therapeutics: Transforming Drug Delivery and Improving Treatment Defence Therapeutics is continuously expanding on its portfolio of solutions to enhance drug delivery and improve treatment outcomes for patients with cancer and infectious diseases. Defence Therapeutics is a Canadian biotechnology company focused on the development of the next generation vaccines, antibody-drug conjugates (ADCs), and anti-cancer small molecule therapeutics. Antibody-drug conjugates or ADCs are a class of biopharmaceutical drugs developed as a targeted therapy for treating cancer. ADCs are designed to target and kill tumour cells, whilst sparing healthy cells. The core of Defence’s technology is centred on enhancing the delivery of proteins, antigens, or drugs into target cells in order to bring forward transformational outcomes for patients who have no effective treatment options. Sébastien Plouffe CEO & Director Defence Therapeutics Inc https://lnkd.in/eFJXymgx #health #vaccindevelopment #drugdelivery #cancer #cancertreatment

Defence Therapeutics: Transforming Drug Delivery and Improving Treatment

Defence Therapeutics: Transforming Drug Delivery and Improving Treatment

https://www.innovationnewsnetwork.com

To view or add a comment, sign in

Explore topics